*Gulp* Much to the relief of the needle-shy, the FDA has just approved a second oral GLP-1 drug, following the release of the semaglutide Wegovy pill in January. But this new tablet, from pharma giant Eli Lilly, promises to be even more convenient than its predecessor with similar, if slightly less drastic, weight-trimming results. The … Read more
The US Food and Drug Administration announced on Thursday its approval of a new, higher-dose Wegovy (semaglutide) injection. The 7.2 mg dosage, called Wegovy HD, is intended for weight loss and long-term weight loss maintenance for adult patients. It is triple the previous maximum dose of 2.4 mg. This marks the fourth approval in the FDA’s National … Read more
The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the green light this weekend to start selling generic versions of Ozempic and Wegovy, with several other countries set to follow in the months ahead. The move is expected to unleash a wave of cheaper alternatives, dramatically widening … Read more
Downside to dropping pounds? The new pill form of popular GLP-1 drugs contains a compound that could cause troubling side effects. Historically, semaglutide, the active ingredient in Ozempic and Wegovy, has been administered via weekly injections into the fatty tissue just under the skin of the stomach, thigh or upper arm. But due to consumer … Read more
New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. Sometimes, portion control isn’t enough. You know how true the above statement is, especially if you’ve struggled with your weight most of your life. What you might not know is … Read more
The weight-loss drug market just got more crowded — and a lot less painful. The FDA on Monday approved a daily pill version of Novo Nordisk’s Wegovy, making it the first oral GLP-1 obesity treatment cleared for use without injections. “As the first oral GLP-1 treatment for people living with overweight or obesity, the Wegovy … Read more
It might be time to dust off that Costco card. The wholesale giant has partnered with Danish drugmaker Novo Nordisk to offer blockbuster weight-loss medications like Ozempic and Wegovy at deep discounts for members without insurance. “Everyone deserves care that’s simple, reliable and within reach — and we’re proud to lead the way in helping … Read more
What’s feeding your hunger? New research suggests that your motivation for eating that second slice of pizza could influence how well you respond to blockbuster GLP-1s like Ozempic and Wegovy. The study sheds new light on why some people lose up to 20% of their body weight on these drugs — while others barely budge … Read more
Deciding which jab to nab? When it comes to shedding pounds and cinching inches, a new study puts one weight loss drug ahead of another. Published in the New England Journal of Medicine, the study followed 751 obese Americans to test the efficacy and safety of two leading weight loss drugs. Nearly 32% of Zepbound … Read more
The Trump administration on Friday rejected a Biden plan that would have required Medicare and Medicaid to cover obesity drugs and expanded access for millions of people. Under the law that established Medicare’s Part D drug benefits, the program was forbidden from paying for drugs for “weight loss.” The Biden administration’s proposal last November had … Read more
It’s easy to make a medical case for blockbuster weight loss drugs like Wegovy and Zepbound, which have been shown to prevent heart attacks and strokes and save lives. But for the employers and government programs being asked to pay for the medications, the financial case for them is less clear. Are the drugs’ benefits … Read more
A Pennsylvania mom is suing the maker of Ozempic and Wegovy claiming she nearly died from taking the prescription drugs and wasn’t properly warned about potentially harrowing side effects. Juanita Gantt said her doctor prescribed the trendy weight-loss drugs because she had a higher risk for diabetes and wanted to shed more than 20 pounds. … Read more
Weight-loss drugs are taking a big bite out of the food business. People taking meds like Ozempic, Mounjaro and Wegovy — originally developed to treat Type 2 diabetes — spend less on groceries and have a healthier assortment in their basket, according to a new study on shopping behaviors by analytics firm Grocery Doppio. This is because … Read more
Pfizer plans to move a reworked, once-a-day version of its weight-loss pill danuglipron into clinical trials later this year, the company said on Thursday, after scrapping a twice-daily version of the drug late last year. The new drug is part of the second generation of weight-loss pills under development by companies including Eli Lillyand Novo Nordisk … Read more
Researchers say they have uncovered a link between semaglutide — the active ingredient in Ozempic and Wegovy — and sudden vision loss. The risk of developing nonarteritic anterior ischemic optic neuropathy (NAION) is four times higher for diabetics on semaglutide and seven times higher for people taking the drug to lose weight, according to a new study … Read more
Ozempic and Wegovy users are shedding weight — and reducing their boozing, new research finds. Taking the drugs can halve the risk of being diagnosed with alcohol use disorder (AUD) or relapsing, according to a study from the Case Western Reserve University School of Medicine. “This is very promising news in that we may have a … Read more
NEW YORK (AP) — Ever since college, Brad Jobling struggled with his weight, fluctuating between a low of 155 pounds when he was in his 30s to as high as 220. He spent a decade tracking calories on WeightWatchers, but the pounds he dropped always crept back onto his 5-foot-5-inch frame. A little over a … Read more
The popular weight-loss drug Wegovy, which has helped millions of Americans shed pounds, can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are overweight or who have obesity, federal regulators said Friday. The Food and Drug Administration approved a label change requested by drugmaker Novo … Read more
It’s worth the weight. A new injectable helps patients burn fat five times faster than Ozempic and Wegovy, according to the stunning results of a new clinical trial. The drug — currently known as VK2735 — was developed by California biotech company Viking Therapeutics, whose share price surged 80% after the trial results were announced … Read more
Counterfeit versions of weight-loss related medications are “detrimental to the field of obesity medicine” and can pose severe risks to patient health, particularly to those who rely on them most, according to medical experts. There is growing concern that the shortage of these popular weight-loss related drugs has created a market for suspected counterfeits. The World Health … Read more